<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title><![CDATA[Zackary King]]></title>
<link>/profile/zackary-king/zking625/rss20/</link>
<description><![CDATA[]]></description>
<item>
<title><![CDATA[Trinity Insights | The Sunshine Act: Increasing Transparency or Opening Pandora’s Box?]]></title>
<link>http://trinitypharma.com/insights/2012/06/28/sunshine-act-increasing-transparency-or-opening-pandora%E2%80%99s-box</link>
<guid isPermaLink="false">http://trinitypharma.com/insights/2012/06/28/sunshine-act-increasing-transparency-or-opening-pandora%E2%80%99s-box</guid>
<pubDate>Mon, 09 Jul 2012 16:34:15 EDT</pubDate>
<description><![CDATA[Almost two years ago the Centers for Medicare and Medicaid Services (CMS) proposed a new rule that would incorporate the Physician Payments Sunshine Act into health care reform, with the underlying goal of enhancing transparency between drugmakers, physicians and the public. Since then, the healthcare and pharma industries have been buzzing with speculation, questions and concerns over how this mandate will impact patient care, but no one really knows for certain how the bill will impact healthcare and to what extent a little sunshine might change things. Will we enter a new period of transparency and patient awareness, or will the unintended consequences make us wish this Pandora’s Box was never opened?]]></description>
</item>
<item>
<title><![CDATA[SaaS Business Intelligence - it just makes sense]]></title>
<link>http://www.trinitypharma.com/insights/2012/05/11/saas-business-intelligence-it-just-makes-sense</link>
<guid isPermaLink="false">http://www.trinitypharma.com/insights/2012/05/11/saas-business-intelligence-it-just-makes-sense</guid>
<pubDate>Fri, 11 May 2012 16:51:36 EDT</pubDate>
<description><![CDATA[I spoke recently to the commercial leaders of a well-established pharma company who were relaying their frustrations with their current data and business intelligence environment. The complaints were ones I hear frequently – “it’s slow and inflexible,” “it doesn’t contain all of our data and we have quality issues,” “it’s inflexible, complex and expensive to maintain,” “the analytics are not relevant to the changing business.”]]></description>
</item>
<item>
<title><![CDATA[Trinity Insights | Introducing Agile M - Mobile Sales Insights for Life Sciences]]></title>
<link>http://trinitypharmasolutions.com/insights/2011/12/03/introducing-agile-m</link>
<guid isPermaLink="false">http://trinitypharmasolutions.com/insights/2011/12/03/introducing-agile-m</guid>
<pubDate>Wed, 07 Dec 2011 12:17:32 EST</pubDate>
<description><![CDATA[By Zackary King
Since its introduction last year, the iPad has quickly become the life sciences industry’s preferred mobile tool for sales and marketing. Many executives and sales reps have been issued an iPad by their companies, but so far, they haven’t capitalized on the emerging opportunity that mobile devices truly present: access to real-time, convenient, integrated data and insights that improve the speed, quality, and accuracy of business decisions.]]></description>
</item>
</channel>
</rss>